Resolution of clinical and laboratory abnormalities after diagnosis of ventilator-Associated pneumonia in trauma patients

Joseph Swanson, Kathryn A. Connor, Louis J. Magnotti, Martin Croce, Jessica Johnson, G Christopher Wood, Timothy Fabian

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Guidelines advise that patients with ventilator-Associated pneumonia (VAP) should respond clinically by Day 3 of antibiotics. White blood cell (WBC) count, maximum temperature (Tmax), and PaO 2:FIO2 ratio are all said to respond significantly by Day 6. Resolution of abnormalities has not been evaluated in trauma patients. Methods: Retrospective review of trauma patients with VAP. The WBC count, Tmax, and PaO2:FIO2 were evaluated for 16 days after diagnosis. Patients were grouped into uncomplicated VAP, complicated VAP (those with inadequate empirical therapy [IEAT], VAP relapse/superinfection, or acute respiratory distress syndrome), and concurrent infection+VAP (those also infected at another site). Results: There were 126 patients (uncomplicated VAP=29, complicated VAP=69, and concurrent infection+VAP=28). The mean Tmax in patients with uncomplicated VAP decreased significantly from diagnosis to Day 4 (Day 1: 39±0.5 C vs. Day 4: 38.6±0.7 C; p=0.028) but never normalized. Their WBC counts and PaO2:FIO2 did not change significantly over the 16-day follow-up and never normalized. When comparing the three groups, the probability of resolving all three abnormalities was not different (p=0.5). Conclusions: Clinical and laboratory abnormalities in critically injured patients with VAP do not resolve as quickly as suggested in the guidelines. Future studies should evaluate new methods to determine the response to antibiotic therapy in critically injured patients with VAP.

Original languageEnglish (US)
Pages (from-to)49-55
Number of pages7
JournalSurgical Infections
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Ventilator-Associated Pneumonia
Wounds and Injuries
Leukocyte Count
Guidelines
Anti-Bacterial Agents
Superinfection
Adult Respiratory Distress Syndrome
Infection

All Science Journal Classification (ASJC) codes

  • Surgery
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Resolution of clinical and laboratory abnormalities after diagnosis of ventilator-Associated pneumonia in trauma patients. / Swanson, Joseph; Connor, Kathryn A.; Magnotti, Louis J.; Croce, Martin; Johnson, Jessica; Wood, G Christopher; Fabian, Timothy.

In: Surgical Infections, Vol. 14, No. 1, 01.01.2013, p. 49-55.

Research output: Contribution to journalArticle

@article{64bd9894bd9243788c2acf0b27779ec6,
title = "Resolution of clinical and laboratory abnormalities after diagnosis of ventilator-Associated pneumonia in trauma patients",
abstract = "Background: Guidelines advise that patients with ventilator-Associated pneumonia (VAP) should respond clinically by Day 3 of antibiotics. White blood cell (WBC) count, maximum temperature (Tmax), and PaO 2:FIO2 ratio are all said to respond significantly by Day 6. Resolution of abnormalities has not been evaluated in trauma patients. Methods: Retrospective review of trauma patients with VAP. The WBC count, Tmax, and PaO2:FIO2 were evaluated for 16 days after diagnosis. Patients were grouped into uncomplicated VAP, complicated VAP (those with inadequate empirical therapy [IEAT], VAP relapse/superinfection, or acute respiratory distress syndrome), and concurrent infection+VAP (those also infected at another site). Results: There were 126 patients (uncomplicated VAP=29, complicated VAP=69, and concurrent infection+VAP=28). The mean Tmax in patients with uncomplicated VAP decreased significantly from diagnosis to Day 4 (Day 1: 39±0.5 C vs. Day 4: 38.6±0.7 C; p=0.028) but never normalized. Their WBC counts and PaO2:FIO2 did not change significantly over the 16-day follow-up and never normalized. When comparing the three groups, the probability of resolving all three abnormalities was not different (p=0.5). Conclusions: Clinical and laboratory abnormalities in critically injured patients with VAP do not resolve as quickly as suggested in the guidelines. Future studies should evaluate new methods to determine the response to antibiotic therapy in critically injured patients with VAP.",
author = "Joseph Swanson and Connor, {Kathryn A.} and Magnotti, {Louis J.} and Martin Croce and Jessica Johnson and Wood, {G Christopher} and Timothy Fabian",
year = "2013",
month = "1",
day = "1",
doi = "10.1089/sur.2011.128",
language = "English (US)",
volume = "14",
pages = "49--55",
journal = "Surgical Infections",
issn = "1096-2964",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Resolution of clinical and laboratory abnormalities after diagnosis of ventilator-Associated pneumonia in trauma patients

AU - Swanson, Joseph

AU - Connor, Kathryn A.

AU - Magnotti, Louis J.

AU - Croce, Martin

AU - Johnson, Jessica

AU - Wood, G Christopher

AU - Fabian, Timothy

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background: Guidelines advise that patients with ventilator-Associated pneumonia (VAP) should respond clinically by Day 3 of antibiotics. White blood cell (WBC) count, maximum temperature (Tmax), and PaO 2:FIO2 ratio are all said to respond significantly by Day 6. Resolution of abnormalities has not been evaluated in trauma patients. Methods: Retrospective review of trauma patients with VAP. The WBC count, Tmax, and PaO2:FIO2 were evaluated for 16 days after diagnosis. Patients were grouped into uncomplicated VAP, complicated VAP (those with inadequate empirical therapy [IEAT], VAP relapse/superinfection, or acute respiratory distress syndrome), and concurrent infection+VAP (those also infected at another site). Results: There were 126 patients (uncomplicated VAP=29, complicated VAP=69, and concurrent infection+VAP=28). The mean Tmax in patients with uncomplicated VAP decreased significantly from diagnosis to Day 4 (Day 1: 39±0.5 C vs. Day 4: 38.6±0.7 C; p=0.028) but never normalized. Their WBC counts and PaO2:FIO2 did not change significantly over the 16-day follow-up and never normalized. When comparing the three groups, the probability of resolving all three abnormalities was not different (p=0.5). Conclusions: Clinical and laboratory abnormalities in critically injured patients with VAP do not resolve as quickly as suggested in the guidelines. Future studies should evaluate new methods to determine the response to antibiotic therapy in critically injured patients with VAP.

AB - Background: Guidelines advise that patients with ventilator-Associated pneumonia (VAP) should respond clinically by Day 3 of antibiotics. White blood cell (WBC) count, maximum temperature (Tmax), and PaO 2:FIO2 ratio are all said to respond significantly by Day 6. Resolution of abnormalities has not been evaluated in trauma patients. Methods: Retrospective review of trauma patients with VAP. The WBC count, Tmax, and PaO2:FIO2 were evaluated for 16 days after diagnosis. Patients were grouped into uncomplicated VAP, complicated VAP (those with inadequate empirical therapy [IEAT], VAP relapse/superinfection, or acute respiratory distress syndrome), and concurrent infection+VAP (those also infected at another site). Results: There were 126 patients (uncomplicated VAP=29, complicated VAP=69, and concurrent infection+VAP=28). The mean Tmax in patients with uncomplicated VAP decreased significantly from diagnosis to Day 4 (Day 1: 39±0.5 C vs. Day 4: 38.6±0.7 C; p=0.028) but never normalized. Their WBC counts and PaO2:FIO2 did not change significantly over the 16-day follow-up and never normalized. When comparing the three groups, the probability of resolving all three abnormalities was not different (p=0.5). Conclusions: Clinical and laboratory abnormalities in critically injured patients with VAP do not resolve as quickly as suggested in the guidelines. Future studies should evaluate new methods to determine the response to antibiotic therapy in critically injured patients with VAP.

UR - http://www.scopus.com/inward/record.url?scp=84875183568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875183568&partnerID=8YFLogxK

U2 - 10.1089/sur.2011.128

DO - 10.1089/sur.2011.128

M3 - Article

VL - 14

SP - 49

EP - 55

JO - Surgical Infections

JF - Surgical Infections

SN - 1096-2964

IS - 1

ER -